Home > Qtrly Results > Cadila Healthcare

Cadila Healthcare
Quarterly Results Analysis [Jun2022]

Cadila Healthcare is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for Cadila Healthcare
Please provide your vote to see the results

Cadila Healthcare Quarterly Results

Consolidated Jun2022
UnAudited
Mar2022
Audited
Dec2021
UnAudited
Sep2021
UnAudited
Jun2021
UnAudited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
UnAudited
Revenues ₹4,073 Cr ₹3,864 Cr ₹3,655 Cr ₹3,785 Cr ₹4,002 Cr ₹3,670 Cr ₹3,633 Cr ₹3,659 Cr
Expenses ₹3,240 Cr ₹3,146 Cr ₹2,903 Cr ₹2,924 Cr ₹3,030 Cr ₹2,821 Cr ₹2,867 Cr ₹2,845 Cr
Operating Income ₹833 Cr ₹718 Cr ₹753 Cr ₹861 Cr ₹972 Cr ₹850 Cr ₹767 Cr ₹814 Cr
Other Income ₹66 Cr ₹79 Cr ₹61 Cr ₹53 Cr ₹32 Cr ₹-30 Cr ₹27 Cr ₹28 Cr
Interest ₹34 Cr ₹39 Cr ₹31 Cr ₹30 Cr ₹27 Cr ₹23 Cr ₹27 Cr ₹45 Cr
Depreciation ₹181 Cr ₹185 Cr ₹183 Cr ₹185 Cr ₹173 Cr ₹175 Cr ₹176 Cr ₹175 Cr
Profit Before Tax ₹681 Cr ₹573 Cr ₹599 Cr ₹604 Cr ₹803 Cr ₹548 Cr ₹590 Cr ₹490 Cr
Profit After Tax ₹563 Cr ₹464 Cr ₹488 Cr ₹504 Cr ₹646 Cr ₹754 Cr ₹486 Cr ₹390 Cr
EPS ₹5.06 ₹3.88 ₹4.89 ₹29.32 ₹5.73 ₹6.63 ₹5.15 ₹4.62
Industry Peers & Returns1W1M1Y
Cadila Healthcare 8.3% 5.1% -33.9%
SUN PHARMACEUTICAL INDUSTRIES -0.2% 6.2% 16%
DIVIS LABORATORIES -4.7% -1.3% -19.7%
DR REDDYS LABORATORIES 2.6% -5.4% -11%
CIPLA -0.7% 7.8% 13.8%
GLAND PHARMA 4.5% -3.4% -44.2%
PIRAMAL ENTERPRISES 11.2% 13.1% -31.4%
TORRENT PHARMACEUTICALS -1.1% 3.5% 1.4%
ALKEM LABORATORIES -4.9% -5.7% -16.6%

Cadila Healthcare Quarterly Revenues

Revenues
Q-o-Q

5.41 %

Y-o-Y

1.77 %

Quarters Revenues % Change
Jun2022 ₹4,073 Cr
5.41
Mar2022 ₹3,864 Cr
5.71
Dec2021 ₹3,655 Cr
-3.43
Sep2021 ₹3,785 Cr
-5.42
Jun2021 ₹4,002 Cr
9.03
Mar2021 ₹3,670 Cr
1.03
Dec2020 ₹3,633 Cr
-0.71
Sep2020 ₹3,659 Cr -

Cadila Healthcare Quarterly Operating Profit

Operating Profit
Q-o-Q

16.07 %

Y-o-Y

-14.29 %

Quarters Operating Profit % Change
Jun2022 ₹833 Cr
16.07
Mar2022 ₹718 Cr
-4.62
Dec2021 ₹753 Cr
-12.58
Sep2021 ₹861 Cr
-11.43
Jun2021 ₹972 Cr
14.41
Mar2021 ₹850 Cr
10.83
Dec2020 ₹767 Cr
-5.81
Sep2020 ₹814 Cr -
Operating Margins
Q-o-Q

10.12 %

Y-o-Y

-15.81 %

Quarters Operating Margin% % Change
Jun2022 20.45%
10.12
Mar2022 18.57%
-9.81
Dec2021 20.59%
-9.45
Sep2021 22.74%
-6.38
Jun2021 24.29%
4.92
Mar2021 23.15%
9.72
Dec2020 21.1%
-5.13
Sep2020 22.24% -

Cadila Healthcare Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

21.33 %

Y-o-Y

-12.84 %

Quarters Profit After Tax % Change
Jun2022 ₹563 Cr
21.33
Mar2022 ₹464 Cr
-5.04
Dec2021 ₹488 Cr
-3.02
Sep2021 ₹504 Cr
-22.00
Jun2021 ₹646 Cr
-14.33
Mar2021 ₹754 Cr
55.07
Dec2020 ₹486 Cr
24.75
Sep2020 ₹390 Cr -
PAT Margins
Q-o-Q

15.08 %

Y-o-Y

-14.38 %

Quarters PAT Margin(%) % Change
Jun2022 13.81 %
15.08
Mar2022 12 %
-10.18
Dec2021 13.36 %
0.45
Sep2021 13.3 %
-17.54
Jun2021 16.13 %
-21.43
Mar2021 20.53 %
53.55
Dec2020 13.37 %
25.54
Sep2020 10.65 % -

Cadila Healthcare Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

30.41 %

Y-o-Y

-11.69 %

Quarters EPS % Change
Jun2022 ₹5.06
30.41
Mar2022 ₹3.88
-20.65
Dec2021 ₹4.89
-83.32
Sep2021 ₹29.32
411.69
Jun2021 ₹5.73
-13.57
Mar2021 ₹6.63
28.74
Dec2020 ₹5.15
11.47
Sep2020 ₹4.62 -

You may also like the below Video Courses


SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].